Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADRAZOLAM trial: pharmacokinetics of adrenaline infusion during remimazolam anesthesia
jRCT1031230653Not yet recruiting
- Sponsor
- Special Target Research Fund
- Start
- Feb 2024
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of epinephrine in left ventricular dysfunction, aortic stenosis (AS), mitral stenosis (MS) and 3 more, sponsored by Special Target Research Fund. Primary endpoint: Serum adrenaline concentration. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
epinephrine
03
Conditions
left ventricular dysfunctionaortic stenosis (AS)mitral stenosis (MS)aortic insufficiency (AI)mitral regurgitation (MR)
Beyond the preview
Go deeper on jRCT1031230653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031230653.